Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), maker of IZERVAY™ (avacincaptad pegol intravitreal solution), a C5 inhibitor for the treatment of geographic atrophy (GA ...

Atrial fibrillation recurrence after catheter ablation was not significantly linked to major adverse outcomes, regardless of ...

MISSOULA, Mont. — The University of Montana Western will hold its research symposium May 2 and May 3 in the Swysgood Technology Center Great Room. Attendance is free and open to all. Oral ...

Explore how LC-MS technologies are transforming forensic and clinical toxicology by enabling comprehensive compound detection ...

Women using vaginal estrogen had markedly lower sepsis and death rates and fewer hospitalizations than women not using the ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

The Qur’an is a text composed in early Arabic, whose reading is even more challenging than that of the Hebrew Bible or the ...

From word walls to peer presentations, these classroom strategies help students thrive as scientists and English learners.

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

Q1 2025 Earnings Call Transcript April 24, 2025 NovoCure Limited beats earnings expectations. Reported EPS is $-0.31, ...